共 22 条
New Approach Methods (NAMs) Supporting Read-Across: Two Neurotoxicity AOP-based IATA Case Studies
被引:18
|作者:
van der Stel, Wanda
[1
]
Carta, Giada
[2
]
Eakins, Julie
[3
]
Delp, Johannes
[4
]
Suciu, Ilinca
[4
,5
]
Forsby, Anna
[6
]
Cediel-Ulloa, Andrea
[7
]
Attoff, Kristina
[6
]
Troger, Florentina
[8
]
Kamp, Hennicke
[9
]
Gardner, Iain
[10
]
Zdrazil, Barbara
[8
]
Mone, Martijn J.
[1
]
Ecker, Gerhard F.
[8
]
Pastor, Manuel
[11
]
Gomez-Tamayo, Jose Carlos
[11
]
White, Andrew
[12
]
Danen, Erik H. J.
[1
]
Leist, Marcel
[4
]
Walker, Paul
[3
]
Jennings, Paul
[2
]
Bennekou, Susanne Hougaard
[13
]
van de Water, Bob
[1
]
机构:
[1] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands
[2] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Div Mol & Computat Toxicol, AIMMS, Amsterdam, Netherlands
[3] Cyprotex Discovery Ltd, Alderley Pk, Macclesfield, Cheshire, England
[4] Univ Konstanz, Dept Inaugurated Doerenkamp Zbinden Fdn, Chair In Vitro Toxicol & Biomed, Constance, Germany
[5] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany
[6] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden
[7] Uppsala Univ, Dept Organismal Biol, Uppsala, Sweden
[8] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria
[9] BASF, Ludwigshafen, Germany
[10] Certara UK Ltd, Sheffield, S Yorkshire, England
[11] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain
[12] Unilever, Sharnbrook, Beds, England
[13] Tech Univ Denmark DTU, Natl Food Inst, Lyngby, Denmark
关键词:
COMPLEX III DEFICIENCY;
ADVERSE OUTCOME PATHWAY;
NITRIC-OXIDE;
MITOCHONDRIAL;
PHARMACOKINETICS;
DEGUELIN;
NEURONS;
VOLUME;
D O I:
10.14573/altex.2103051
中图分类号:
R-3 [医学研究方法];
R3 [基础医学];
学科分类号:
1001 ;
摘要:
Read-across approaches are considered key in moving away from in vivo animal testing towards addressing data-gaps using new approach methods (NAMs). Ample successful examples are still required to substantiate this strategy. Here we present and discuss the learnings from two OECD IATA endorsed read-across case studies. They involve two classes of pesticides - rotenoids and strobilurins - each having a defined mode-of-action that is assessed for its neurological hazard by means of an AOP-based testing strategy coupled to toxicokinetic simulations of human tissue concentrations. The endpoint in question is potential mitochondrial respiratory chain mediated neurotoxicity, specifically through inhibition of complex I or III. An AOP linking inhibition of mitochondrial respiratory chain complex I to the degeneration of dopaminergic neurons formed the basis for both cases but was deployed in two different regulatory contexts. The two cases also exemplify several different read-across concepts: analogue versus category approach, consolidated versus putative AOP, positive versus negative prediction (i.e., neurotoxicity versus low potential for neurotoxicity), and structural versus biological similarity. We applied a range of NAMs to explore the toxicodynamic properties of the compounds, e.g., in silico docking as well as in vitro assays and readouts - including transcriptomics - in various cell systems, all anchored to the relevant AOPs. Interestingly, although some of the data addressing certain elements of the read-across were associated with high uncertainty, their impact on the overall read-across conclusion remained limited. Coupled to the elaborate regulatory review that the two cases underwent, we propose some generic learnings of AOP-based testing strategies supporting read-across.
引用
收藏
页码:615 / 635
页数:21
相关论文